Click Therapeutics: How Digital Health Drives a Paradigm Shift in Health Care
Emile Westergaard CFA is Chief Business Officer & Board Member at Click Therapeutics, Inc. overseeing business development and payer strategies. Previously Emile Westergaard, CFA was a partner at Perella Weinberg Partners (PWP) where he was portfolio manager of the PWP Tokum Global Healthcare Investment Strategies. PWP acquired Tokum in 2010 which Emile founded in 2007. While running PWP Tokum, Emile received a number of Awards including Institutional Investor Rising Stars of Hedge Funds, UCITS Hedge Best Performing New Fund of 2011 and HFM 2012 Best Long/short Equity under $250m. Prior to founding Tokum, Emile was the Portfolio Manager for global healthcare at Amaranth LLC and director of research for the Pequot Healthcare Funds. Emile was also Global Head of Medical Technology Equity Research at UBS as well an analyst at Bear Stearns. Emile has a bachelors degree from University of Chicago.
About Click Therapeutics
Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ applications to benefit people with brain disorders and neuropsychiatric dysfunction. Click Therapeutics™ digital interventions enable change within individuals, and can be used independently or in conjunction with biomedical treatments. Our Clickometrics™ adaptive data science platform continuously personalizes user experience to drive cognitive and behavioral outcomes. As the leader in Digital Therapeutics™ solutions, our company is building the brains behind digital health.
7:00 pm // Networking and refreshments
7:15 pm // Presentation, followed by Q&A
8:00 pm // Free time for networking
8:30 – 9:00 pm // Event ends